Literature DB >> 17351535

[Olfaction and neurological diseases: a review of the literature].

G Demarquay1, P Ryvlin, J P Royet.   

Abstract

Olfactory disorders are often misjudged and rarely rated in the clinical setting. They are nevertheless described in a wide range of neurological disorders, and their evaluation can be useful for diagnosis. Usually irreversible olfactory dysfunction is a well-known complication after head trauma. Severe changes in olfactory tests are observed in Parkinson's disease. Dysfunction is present at disease onset and evidenced with all behavioral tests. Regarding other parkinsonian syndromes, olfactory performances are severely impaired in Lewy body disease, less pronounced in multiple system atrophy and usually preserved in corticobasal degeneration. Olfactory deficits are an early feature in Alzheimer's disease and worsen with disease progression. Rarely reported by patients, they must be searched for with olfactory tests. Though epilepsy is mainly known for its olfactory hallucinatory disorders, alterations of olfactory abilities are also described, especially in mesial temporal epilepsy. Disorders of olfactory perception are finally reported in patients with multiple sclerosis and migraine. After a reminder of anatomical data on the olfactory system, and the different methods of testing used to rate olfactory performances, the current review focuses on the type of olfactory dysfunction and damaged brain areas of the olfactory system encountered in the main neurological diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17351535     DOI: 10.1016/s0035-3787(07)90387-2

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  15 in total

1.  Decreased olfactory bulb volumes in patients with fibromyalgia syndrome.

Authors:  Selçuk Sayılır; Neşat Çullu
Journal:  Clin Rheumatol       Date:  2017-07-26       Impact factor: 2.980

2.  Olfactory memory impairment in neurodegenerative diseases.

Authors:  Biju Bahuleyan; Satendra Singh
Journal:  J Clin Diagn Res       Date:  2012-10

3.  Inflammation-induced subventricular zone dysfunction leads to olfactory deficits in a targeted mouse model of multiple sclerosis.

Authors:  Vanja Tepavčević; Françoise Lazarini; Clara Alfaro-Cervello; Christophe Kerninon; Kazuaki Yoshikawa; José Manuel Garcia-Verdugo; Pierre-Marie Lledo; Brahim Nait-Oumesmar; Anne Baron-Van Evercooren
Journal:  J Clin Invest       Date:  2011-11-07       Impact factor: 14.808

Review 4.  Assessment of direct knowledge of the human olfactory system.

Authors:  Gregory Lane; Guangyu Zhou; Torben Noto; Christina Zelano
Journal:  Exp Neurol       Date:  2020-04-09       Impact factor: 5.330

5.  Olfactory impairment in patients with the fibromyalgia syndrome and systemic sclerosis.

Authors:  Howard Amital; Nancy Agmon-Levin; Netta Shoenfeld; Yoav Arnson; Daniela Amital; Pnina Langevitz; Alexandra Balbir Gurman; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

6.  Kinetics of satratoxin g tissue distribution and excretion following intranasal exposure in the mouse.

Authors:  Chidozie J Amuzie; Zahidul Islam; Jae Kyung Kim; Ji-Hyun Seo; James J Pestka
Journal:  Toxicol Sci       Date:  2010-05-13       Impact factor: 4.849

7.  Evaluation of Olfactory Bulb Volumes in Patients With Rheumatoid Arthritis: A Retrospective Study.

Authors:  Selçuk Sayilir; Neşat Çullu; Gönen Mengi; Timur Ekiz
Journal:  Arch Rheumatol       Date:  2019-04-22       Impact factor: 1.472

8.  Purification and comparative neurotoxicity of the trichothecenes satratoxin G and roridin L2 from Stachybotrys chartarum.

Authors:  Zahidul Islam; Junko Shinozuka; Jack R Harkema; James J Pestka
Journal:  J Toxicol Environ Health A       Date:  2009

9.  Neuroleptic-induced parkinsonism is associated with olfactory dysfunction.

Authors:  Stephanie Krüger; Antje Haehner; Claudia Thiem; Thomas Hummel
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

10.  Satratoxin G-induced apoptosis in PC-12 neuronal cells is mediated by PKR and caspase independent.

Authors:  Zahidul Islam; Colleen C Hegg; Hee Kyong Bae; James J Pestka
Journal:  Toxicol Sci       Date:  2008-06-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.